Skip to main content

Advertisement

SpringerLink
Log in

The global landscape of cancer cell therapy

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Global geographic distribution of 753 cell therapies in development.
Figure 2: Top 30 targets in cancer cell therapy.

Author information

Authors and Affiliations

  1. Jun Tang, Vanessa M. Hubbard-Lucey, Jill O'Donnell-Tormey, Laura Pearce and Aiman Shalabi are at Cancer Research Institute, New York, NY, USA,

    Jun Tang, Vanessa M. Hubbard-Lucey, Laura Pearce, Jill O'Donnell-Tormey & Aiman Shalabi

Authors
  1. Jun Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vanessa M. Hubbard-Lucey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Pearce
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jill O'Donnell-Tormey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aiman Shalabi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Tang.

Ethics declarations

Competing interests

L.P. and A.S. are not employees but consultants to Cancer Research Institute. All other authors declare no competing interests.

Related links

PowerPoint slides

Supplementary information

Supplementary Figure 1

Numbers of different types of cell therapies in development. (PDF 110 kb)

Supplementary Figure 2

The number of different types of cell therapies in development per country. (PDF 154 kb)

Supplementary Figure 3

The contribution of academic institutes to cancer cell therapy development. (PDF 122 kb)

Supplementary Table

The list of trials that combine cell therapies with anti-PD1/L1 agents. (PDF 76 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, J., Hubbard-Lucey, V., Pearce, L. et al. The global landscape of cancer cell therapy. Nat Rev Drug Discov 17, 465–466 (2018). https://doi.org/10.1038/nrd.2018.74

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2018.74

  • Springer Nature Limited

This article is cited by

Search

Navigation